Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.24.1.u1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table summarizes select operating results for each reportable segment (in millions).
Three Months Ended March 31, Three Months Ended March 31,
2024 2023
Revenues
Medical $ 66.8  $ 66.4 
Technologies 125.8  115.7 
Consolidated revenues $ 192.6  $ 182.1 
Segment Income (Loss) from Operations
Medical $ 1.4  $ 0.7 
Technologies 12.6  5.5 
Total segment income from operations 14.0  6.2 
Corporate and other (18.9) (19.8)
Consolidated loss from operations $ (4.9) $ (13.6)
Revenue from External Customers by Geographic Areas
The following details revenues by geographic region. Revenues generated from external customers are attributed to geographic regions through sales from site locations (i.e., point of origin) (in millions).
Revenues
Three Months Ended March 31, Three Months Ended March 31,
2024 2023
North America
Medical $ 60.4  $ 60.7 
Technologies 58.6  55.2 
Total North America 119.0  115.9 
Europe
Medical 6.4  5.7 
Technologies 61.4  53.1 
Total Europe 67.8  58.8 
Asia Pacific
Medical —  — 
Technologies 5.8  7.4 
Total Asia Pacific 5.8  7.4 
Total revenues $ 192.6  $ 182.1 
Revenue from External Customers by Products and Services
The following details revenues by product category (in millions):
Revenues
Three Months Ended March 31, Three Months Ended March 31,
2024 2023
Medical segment:
Medical $ 66.8  $ 66.4 
Technologies segment:
Reactor Safety and Control Systems 50.3  42.1 
Radiological Search, Measurement, and Analysis Systems 75.5  73.6 
Total revenues $ 192.6  $ 182.1 
Disaggregation of Revenue
The following details revenues by timing of recognition (in millions):
Revenues
Three Months Ended March 31, Three Months Ended March 31,
2024 2023
Point in time $ 126.9  $ 118.3 
Over time 65.7  63.8 
Total revenues $ 192.6  $ 182.1